Tampilkan postingan dengan label WE. Tampilkan semua postingan
Tampilkan postingan dengan label WE. Tampilkan semua postingan

Sabtu, 01 April 2017

Do We Have To Accept Chronic Neuropathy


Today's post from jennifermartinpsych.com (see link below) offers some wise words and advice about 'accepting' the fact that you may be living with chronic pain and by doing so, you somehow wave a magic wand that makes it all okay from that point on. Many self-help sites urge us to accept our chronic condition and that if we don't we're being unrealistic and somehow weak. This article however advises that we should indeed accept the reality of our situation but that doesn't mean giving in to it! Worth a read if you're having trouble resisting throwing bricks at the kids!

Accepting Chronic Pain: Is it Necessary? 
Jennifer Martin, Psy.D Clinical Psychologist PSY 27586 August 3, 2015

As published on Pain News Network (www.painnewsnetwork.com) on March 25, 2015

A patient of mine told me the other day, “I don’t think I will ever be able to accept my chronic pain. It has completely changed my life.”

I think this is something that most people with chronic pain contend with at some point in time; wanting to hold onto hope that their diagnosis isn’t chronic or not wanting to come to the realization that they will have to live with the pain forever.

When most people hear the word “acceptance” they equate it with the notion that they should feel that it’s okay or it’s alright to have a chronic condition. Many people don’t ever feel okay about having to live with pain or an illness for the rest of their lives. It is not something that is easy to get used to and it’s not fair.
Accepting chronic pain does not mean giving into it and it doesn’t mean that you stop looking for treatment.
Accepting chronic pain does not mean accepting a lifetime of suffering.
Accepting chronic pain does not mean you are never allowed to feel angry or sad.

Accepting chronic pain does not mean that you have to give up hope for the future.

When I use the word “acceptance,” I mean accepting the reality of your situation and recognizing that this new reality could be permanent. Those of us with chronic conditions may never like this reality and it may never be okay, but eventually it is necessary to accept it and learn to live life with it. It is the new norm with which we must learn to live.

Acceptance also involves making adaptations and alterations to our lives. We must find new things that bring us joy and we must have hope for the future.
Accepting chronic pain means learning to live again.
Accepting chronic pain means advocating for ourselves and our health so that we can be as healthy as possible.
Accepting chronic pain means learning our limits and learning to cope with feelings of guilt when we have to say “no.”
Accepting chronic pain means being able to look at your diagnosis as something you have, not who you are. Your condition does not define you.
Accepting chronic pain means re-evaluating your role as a husband/wife, mother/father, etc. as well as your life’s goals -- and figuring out how you can maintain these roles and attain your goals with your chronic condition.

For many of us, learning to accept our chronic condition isn’t easy. It is a learning process with a lot of ups and downs. It is something we may resist and something we may think impossible. It is difficult to accept something that has completely changed our lives and possibly the direction we thought our life was going to take.

Why is it necessary to accept your chronic condition?


Once you are diagnosed with a chronic condition, it will be always be with you. The sooner you are able to begin the process of acceptance, the sooner you will be able to learn exactly how to live with it. It is also how you will learn to cope.

Accepting chronic pain means learning to live life in a different way than before your diagnosis. It means learning to pace your activities, educating yourself, taking your medications, advocating for yourself, and surrounding yourself with support. It also means accepting that some aspects of your condition are out of your control.

Chronic pain can be unpredictable. There may be days when you feel in control of your pain and you are able to accomplish everything you would like to. There may also be days when your pain is unbearable, you feel angry about your situation, and all you can do is rest. Accepting your chronic pain means adjusting and adapting to the ways in which your life is different now that you may be living with this kind of unpredictability.

Your life may never go back to what it was prior to your chronic pain. But that doesn’t mean you can’t live a happy, successful, hopeful life with pain. Learning to accept your chronic pain can help you get there.

http://www.jennifermartinpsych.com/yourcolorlooksgoodblog/2015/8/3/accepting-chronic-pain-is-it-necessary

Jumat, 25 November 2016

INFANT BRAINS DEVELOP YEARS FASTER THAN WE THOUGHT


Scientists from the University of Louvain have discovered that a key element of infant brain development occurs years earlier than previously thought.
The way we perceive faces -- using the right hemisphere of the brain -- is unique and sets us apart from non-human primates. It was thought that this ability develops as we learn to read, but a new study published in the journal eLife shows that in babies as young as four months it is already highly evolved.
"Just as language is impaired following damage to the brain's left hemisphere, damage to the right hemisphere can impair our ability to distinguish faces so it is critical to understand how it develops," says co-author Bruno Rossion, Principal Investigator at the University of Louvain.
Researchers used a cap fitted with electrodes to monitor the brain activity of 15 babies as they sat on their mothers' laps and watched a rapid succession of images over 20 seconds. They were shown 48 images of faces that differed in viewpoint, colour, lighting, and background, interspersed with 200 images of animals, plants, and human-made objects.
Each image was shown for only 166 milliseconds, the same rate used for adult studies. Compared to other images, the appearance of a face was shown to coincide with a specific spike in stimulation of the right hemisphere of the brain. The difference between the right and the left hemisphere was even more pronounced than in the same study with adults, confounding previous assumptions.
"Given the enormous resources devoted to digital face recognition, the babies' brain accomplishment is not trivial," says Rossion. "The success of this research method in babies demonstrates that it can be used in all ages to improve our understanding of how we develop the ability to perceive complex images."
Humans far outperform computer algorithms in categorizing natural visual images. The face is such a frequent and socially important stimulus in human development that it is ideal for studying how we develop the ability to visually categorise objects.
A fundamental element of face perception is our ability to tell individuals apart. The authors can now use the same methods to define when this emerges and how it develops with age.
"Parents and carers are already aware of how quickly babies' brains develop but, until now, gathering evidence has been hard due to the limitations of the methods used," says Rossion.



Selasa, 15 November 2016

Are We Close To Restoring Neuropathy Nerve Damage


Today's post from journals.lww.com/ (see link below) is a doctor's answer to a patient's query about the possibility of ever repairing damaged nerves. His answer suggests that gene therapy may well be the answer in the future. He also quite rightly says that more research is urgently needed but research needs funding. Well worth a read.
 

What's on the horizon for restoring nerve function in peripheral neuropathy?
Smith, A. Gordon M.D.
Neurology Now:
April/May 2014 - Volume 10 - Issue 2 - p 34
 
doi:10.1097/01.NNN.0000446167.75771.61


 Q What's on the horizon for restoring nerve function in peripheral neuropathy? Will there ever be a way to quiet the faulty nerves, as opposed to masking the pain with drugs like gabapentin and oxycodone?

DR. A. GORDON SMITH RESPONDS:

A It is estimated that more than 20 million Americans have peripheral neuropathy, making it one of the most common neurologic conditions. Peripheral neuropathy is caused by damage to the peripheral nervous system, which is responsible for sending information back and forth between the brain and spinal cord to every other part of the body. The condition often causes weakness, numbness, and pain in the hands and feet, but it may also occur in other areas of the body. Because peripheral neuropathy is not a single disease but rather a symptom with many possible causes, it may be difficult to diagnose and to treat.

However, different forms of peripheral neuropathy may also share common mechanisms of nerve injury. This means that discovery of a treatment for one form of peripheral neuropathy might benefit others.

Diabetes is the most frequent cause of peripheral neuropathy. In many cases, the cause of peripheral neuropathy is never known (called idiopathic peripheral neuropathy). Patients, physicians, and researchers are all interested in discovering effective therapies to slow progression, improve pain control, and hopefully reverse nerve injury in peripheral neuropathy.

Recent advances in uncovering the genetics of peripheral neuropathy have been made. Researchers have discovered that some people with painful idiopathic peripheral neuropathy have a mutation in a particular gene. This discovery has led to new studies—including planned human trials—exploring these genetic mutations as potential targets for treatment.

In addition, patients are being actively recruited for a number of exciting clinical trials including studies of growth factors (groups of proteins that stimulate the growth of specific tissues) delivered using gene therapy technology, which allows targeted delivery for peripheral neuropathy caused by diabetes. (Read more on these therapies at bit.ly/1eaBc0H.)

For many neuropathies caused by an immune attack of the nerves, good therapies already exist and others are in development. The outlook for these forms of peripheral neuropathy is even more hopeful. For patients with chronic inflammatory demyelinating polyradiculoneuropathy (a rare and chronic condition characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms), the use of corticosteroids or intravenous immunoglobulin (IVIg)—alone or in combination with immunosuppressant drugs—is effective. However, better treatments are needed for patients who do not respond to currently available approaches.

There is even hope for patients with certain types of genetic neuropathies. Several promising experimental treatments are being studied for familial amyloid polyneuropathy, a rare genetic condition where impaired nerve function is caused by amyloid protein deposits in peripheral nerves.

While the lack of a recognized underlying cause for idiopathic peripheral neuropathy is frustrating, we have learned a great deal about this disorder over the past decade. A number of studies now link obesity and its related metabolic consequences (such as insulin resistance and elevated lipids in the blood) with peripheral neuropathy. In addition, several studies suggest that successful diet and exercise can improve nerve regeneration and improve symptoms including pain. This provides a non-drug treatment approach that would immediately benefit many people with peripheral neuropathy.

Despite all of this good news, more research is urgently needed. Relative to the number of patients who have neuropathy, very few research grants are funded. To help change this, consider joining one of the patient advocacy organizations focused on neuropathy. For example, the Neuropathy Association has many programs to encourage involvement and advocacy: www.neuropathy.org.

© 2014 American Academy of Neurology

http://journals.lww.com/neurologynow/Fulltext/2014/10020/What_s_on_the_horizon_for_restoring_nerve_function.15.aspx

Jumat, 11 November 2016

How Careful Do We Need To Be With Medical Marijuana


Today's post from webmd.com (see link below) looks at a possible warning about medical cannabis and pain problems. This blog is broadly in favour of neuropathy patients trying medical cannabis to relieve their neuropathic symptoms, largely because it remains one of the very few proven methods of doing this. However, all marijuana is not the same and like anything else, you need to dose it to your needs and be careful not to overdo it. This article talks about so-called 'skunk' marijuana, which is super strong and highly potent. It raises question marks as to what this could do to the brain and advises caution to say the least. However, the conclusions are that for pain relief, these warnings can be seen as speculative and a little vague. Lots of people and organisations have their own agendas when it comes to marijuana - taking good advice and doing as much of your own research as possible is strongly advised and what may work for you may not work for others - careful dosage is the key.


Powerful New Pot May Harm the Brain
But marijuana advocate calls the study 'speculative'

By Dennis Thompson HealthDay Reporter WebMD News from HealthDay

WEDNESDAY, Dec. 2, 2015 (HealthDay News) -- Smoking high-potency marijuana might damage nerve fibers that connect the brain's two hemispheres, a new study reports.

MRI scans of nearly 100 people -- including some diagnosed with psychosis -- associated frequent use of high-potency "skunk" marijuana with damage to the corpus callosum, the largest white matter structure in the brain.

"We found that frequent use of high-potency cannabis significantly affects the structure of white matter fibers in the brain, whether you have psychosis or not," said senior researcher Dr. Paola Dazzan, of the Institute of Psychiatry, Psychology & Neuroscience at King's College London.

Further, her team said the damage appears to be dose-dependent. "This reflects a sliding scale where the more cannabis you smoke and the higher the potency, the worse the damage will be," Dazzan said in a college news release.

This is vital information, given that the potency of street marijuana has increased over the last decade, the study authors said.

Reactions to the findings in the United States were mixed, however.

Dr. Scott Krakower, assistant unit chief of psychiatry at Zucker Hillside Hospital in Glen Oaks, N.Y., agreed that the study "supports the idea that using high-potency marijuana can be detrimental."

The upshot? "People should be aware that using this agent isn't benign, and that there are changes to the brain," he said.

But marijuana advocates said the study had limitations.

The damage observed by the researchers appears to be very minor, amounting to a "2 percent change in the corpus callosum" structure, said Mitch Earleywine, chair of NORML, a group that promotes marijuana legalization.

Earleywine, who is also a professor of psychology at the State University of New York, Albany, added that the researchers did not measure the study participants' memory or brain function. "So we have no idea if this had any impact on anything that matters, like memory or impulsivity or depressive symptoms," he said.

For this study, researchers used MRI to examine white matter in the brains of 56 patients who had been diagnosed with psychosis, as well as 43 healthy people from South East London.

The researchers specifically examined the corpus callosum, an area of the brain particularly rich in receptors that respond to THC, the chemical in pot that produces intoxication.

Participants also were asked about their drug use, including the potency of the marijuana they typically use.

Researchers said they were particularly interested in "skunk" marijuana, since previous studies have shown it induces psychotic symptoms, or a break from reality.

"Skunk" is British slang for pot that is highly fragrant and therefore assumed to have higher potency, said Paul Armentano, deputy director of NORML.

The study found that frequent use of high-potency cannabis was linked to significantly higher mean-diffusivity -- a marker of damage in white matter structure -- in the corpus callosum.

However, Earleywine questioned why the researchers didn't look at the hippocampus or areas associated with memory, which are the brain areas that most marijuana studies consider.

The corpus callosum "is a brain area that usually focuses on communication between the hemispheres, or tasks like finding the words for your emotions or having the right hand know what the left hand is doing," he said, adding that the study didn't measure any of these functions.

The researchers also appeared to rely on the participants' own description of both their marijuana use and the potency of their pot, Armentano said.

"It's all rather arbitrary and speculative," he said.

Sean Clarkin is director of strategy and program management with the Partnership for Drug-Free Kids. He said this study should open the door for a healthy "periodic check-in" on a person's marijuana use, to keep it from becoming too frequent or involving increasingly potent pot.

"It provides some scientific basis to say let's be more vigilant than we've been, particularly in the progression from occasional to habitual use," Clarkin said.

The study was published online recently in the journal Psychological Medicine.

http://www.webmd.com/mental-health/addiction/news/20151202/powerful-new-pot-may-harm-the-brain-researchers-say

Selasa, 11 Oktober 2016

The Neurotoxins Poisons We Consume Daily Can Harm Our Nervous Systems


Today's post from dralexjimenez.com (see link below) falls under the category of 'just saying!' posts because it is unlikely that many people will change their habits after reading the warnings below...and yet maybe we should...for the sake of our long-suffering nerves. It's all about neurotoxins, which basically means, common substances in our daily lives that can harm or further damage our neurological systems. Remember also; the word 'toxin' means poison! Well worth a read.


Common Neurotoxins and their Effects on the Body By Dr. Alex Jimenez March 9, 2017

Neurotoxins are substances which can interfere with nerve cells by overstimulating them to death or interrupting the electrical activities of nerves and their communication process, altering the normal function of the nervous system.

Common symptoms associated with the consumption of neurotoxins can manifest immediately after ingestion or they may be delayed. Symptoms include: weakness in the extremities; tingling sensations or numbness; memory loss; loss of vision and/or intellect; uncontrollable obsessive and/or compulsive behaviors; delusions; headaches; cognitive and behavioral issues; and sexual dysfunction. Also, people with certain types of disorders can be more vulnerable to these substances.

Research studies have demonstrated that neurotoxins can shorten the life span of nerve cells. In addition, these substances have been associated with the development of brain disorders, peripheral neuropathy as well as neurodegenerative diseases, such as Alzheimer’s, Huntington’s Chorea and Parkinson’s disease.

To make matters worse, the availability of neurotoxins has increased dramatically within the last few decades. A majority of the neurotoxins our bodies absorb are found in the food we eat and the water we drink. Even worse, these can also be found in baby food.

Neurotoxins In Food

If you have children, it’s important to be aware of the following ten neurotoxins listed below. Because kid’s bodies are still developing, they are often the most vulnerable to the effects of consuming these dangerous substances. The majority of food products that contain neurotoxins are listed on their ingredients list. Processed foods, such as chips and candy, are generally supplied with a load of neurotoxins. It’s best to avoid consuming any food or drink containing the following neurotoxins listed below.


10 Neurotoxins To Avoid 

 
Aspartame (best known as Equal, AminoSweet, NutraSweet and Spoonful): This substance is very commonly added to sugar-free products, such as sugar-free gums and drinks. Most aspartame is made from the fecal matter of genetically modified bacteria. Research studies have associated the consumption of aspartame to migraines, obesity, kidney failure, blindness, seizures, neurological disorders, mental illness, brain tumors and diabetes.


Monosodium glutamate (also known as MSG or sodium glutamate): This substance is common in junk food, fast food and most restaurant food, canned food and even in baby food. Independent researchers believe that ingesting MSG, or monosodium glutamate, plays a considerable role in the development of neurodegenerative brain diseases, including Alzheimer’s, Parkinson’s and Huntington’s disease. MSG is frequently disguised on ingredient labels under alternative names like hydrolyzed, or vegetable protein, plant protein extract, sodium caseinate, calcium caseinate, yeast extract, textured protein, TVP, autolyzed yeast, carrageenan, malt extract, malt flavouring, bouillon, seasonings, spices and natural flavoring. 


Sucralose (or Splenda): This artificial sweetener alternative is very popular in sugar-free products, especially sugar-free drinks. Sucralose was accidentally discovered during a research focused on creating a new insecticide, which is why some researchers propose that sucralose should be listed in the insecticide category. Sucralose has been identified as a chlorinated compound. When the body breaks down this type of chlorinated compound, it releases toxic chemicals into the bloodstream.


Aluminum: This type of metal can frequently be found in our drinking water as well as in over-the-counter antacids and vaccines. Aluminum is a difficult substance for the body to absorb, however, citrate or citric acid tremendously increases its absorption. Vaccines are some of the highest factors which contribute to aluminum toxicity, primarily because the aluminum is injected directly into the body.


Mercury:
This heavy metal is common in fish products, vaccines and amalgam fillings, also referred to as silver fillings. Mercury can be found in our drinking water as well. Mercury has been identified to be one of the most toxic neurotoxins because it destroys brain tissue.


Fluoride (sodium fluoride): This substance is very commonly found in drinking water and conventional toothpaste. Fluoride was utilized to exterminate rats before it was introduced into consumer products. The fluoride used for the products we consume is a mixture of a variety of chemicals which can be hazardous to the body. Not to be confused with the natural calcium fluoride, sodium fluoride can be found listed on the warning labels of fluoridated toothpaste products.


Hydrolyzed vegetable protein: This harmful food ingredient is very common in certain junk foods. Hydrolyzed vegetable protein contains high concentrations of the substances glutamate and aspartate. In high levels, glutamate and aspartate can overstimulate nerve cells.


Calcium caseinate: This substance is frequently found in the ingredient list of many protein supplements, energy bars and junk food. Due to its harmful properties, this neurotoxin can damage the brain and cause other neurological issues.


Sodium caseinate: This type of protein is common in dairy products and junk food. It has been associated to the development of gastrointestinal complications and has even been linked to autism.


Yeast extract: A popular food ingredients in many processed foods, such as canned food. It is also toxic to the brain. 


Sugar: The Most Common Neurotoxin

While the above mentioned neurotoxins can be commonly found in higher concentrations on a majority of the foods we eat today, there is one substance that people consume more frequently than all the others: sugar or table sugar. Refined sugar is not as toxic as aspartame but it can be toxic enough to cause considerable harm to the body when it’s consumed on a regular basis.

When you eat a fruit, for instance, you are not just ingesting sugar and water, but also synergistic components, such as mineral activators, enzymes, co-vitamin helpers and fiber. It’s these components that help the body effectively metabolize all the nutrients of the fruit.

Without the help of these synergistic components, sugar cannot be metabolized safely. In fact, certain elements of the sugar are broken down into toxic chemicals instead. When the body metabolizes refined sugar, toxic metabolites are released into the body. These metabolites can then considerably impair the respiration process of the cells.


Other Common Neurotoxins

Other common neurotoxins which can be found in some of the favorite processed foods we consume are chemical food additives, preservatives and sweeteners. Numerous research studies have been conducted on food additives and their toxic, damaging affect on the nerve cells in our body. Brain cells and the peripheral nerves are the most affected by these substances, which can also have a cumulative effect on the body over time.

Monosodium glutamate
, or MSG, and artificial sweeteners can gradually cause considerable damage to nerve cells, which may lead to peripheral neuropathy or even worse, Alzheimer’s disease. Yet, these ingredients are found in the foods and beverages we consume daily. The average household has diet beverages, salad dressings, canned soups, condiments, crackers, junk food and many other of these types of foods and drinks. Even baby foods contain many of these neurotoxins.

Whether or not you suffer from any neurological dysfunction, everyone should avoid consuming these harmful chemicals. Over a period of decades, they can cause, not only peripheral neuropathy but, damage to brain cells as well, leading to memory loss, confusion, dementia, including Alzheimer’s and other serious neurological diseases such as Parkinsons.

For more information, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .

https://www.dralexjimenez.com/common-neurotoxins-and-their-effects-on-the-body/

Senin, 10 Oktober 2016

Bring it on! We need to interrupt the morphine spiral!


Powerful New Painkiller With No Apparent Side Effects or Addictive Qualities, May Be Ready in a Year
ScienceDaily (Jan. 30, 2011) — A powerful new painkiller, which was developed on the basis of the research conducted at Stony Brook University and with no apparent side effects or addictive qualities, may now be only a year or two from the consumer market.


--------------------------------------------------------
"This offers a major paradigm shift in the control of pain," declares Dr. Simon Halegoua, Professor of Neurobiology & Behavior at Stony Brook who in the 1990s, teamed up with fellow Stony Brook professors Dr. Gail Mandel and Dr. Paul Brehm to identify a novel sodium ion channel involved in the transmission of pain. They predicted that a drug aimed at blocking this channel, PN1/Nav 1.7, would control pain. PN1 (Peripheral Neuron 1), is uniquely expressed in peripheral nerves such as those involved in pain transduction.

"When a patient is given an opiate like morphine, pain signals are still transmitted from sensory nerves to the central nervous system. Morphine action throughout the brain reduces and alters pain perception, but it also impairs judgement and results in drug dependence," explains Halegoua, also director of the Center for Nervous System Disorders at Stony Brook University. "With drugs targeting the PN1/Nav1.7 sodium ion channel, the pain signals would not be transmitted, even by the sensory nerves. And since the central nervous system is taken out of the equation, there would be no side effects and no addictive qualities."

The potential for such drugs is enormous -- the reduction or elimination of pain for patients with cancer, arthritis, migraine headaches, muscle pain, pain from burns, and pain from other debilitating diseases.

He notes that drugs in both oral and topical ointment forms, based on the research he conducted in a basement laboratory at Stony Brook with Mandel, a molecular biologist, and Brehm, an electrophysiologist, are currently in Phase II clinical trials in England and Canada.

The Research Foundation of the State University of New York is the holder of the various patents originating from the work of the Stony Brook researchers. Icagen Inc., now in partnership with Pfizer, holds the exclusive license to these patents and has announced their own drug has now entered Phase I clinical trials in the U.S.
Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Stony Brook University.